Work

Phase I study of 24-hour continuous intravenous infusion of recombinant human tumor necrosis factor.

Year: 1988

Type: article

Study design: Clinical Trial

Source: PubMed

Authors: T Steinmetz, M Schaadt, R Gähl, V Schenk, V Diehl, M Pfreundschuh

Institution: University of Cologne

Language: English

Topic: Monoclonal and Polyclonal Antibodies Research

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2407381120

FWCI: 1.168

Cites:

Cited by: 32

Related to: 10